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Abstract
Understanding the properties of viruses preferentially
establishing infection during perinatal transmission of human
immunodeficiency virus type 1 (HIV-1) is critical for the
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development of effective measures to prevent transmission. A
previous study demonstrated that the newly transmitted viruses
(in infants) of chronically infected mother–infant pairs (MIPs)
were fitter in terms of growth, which was imparted by their
envelope (Env) glycoprotein V1–V5 regions, than those in the
corresponding chronically infected mothers. In order to
investigate whether the higher fitness of transmitted viruses was
conferred by their higher entry efficiency directed by the V1–V5
regions during perinatal transmission, the fusogenicity of Env
containing V1–V5 regions derived from transmitted and non-
tranmsmitted viruses of five chronically infected MIPs and two
acutely infected MIPs was analysed using two different cell–cell
fusion assays. The results showed that, in one chronically
infected MIP, a higher fusion efficiency was induced by the infant
Env V1–V5 compared with that of the corresponding mother.
Moreover, the V4–V5 regions played an important role in
discriminating the transmitted and non-transmitted viruses in this
pair. However, neither a consistent pattern nor significant
differences in fusogenicity mediated by the V1–V5 regions
between maternal and infant variants was observed in the other
MIPs. This study suggests that there is no consistent and
significant correlation between viral fitness selection and entry
efficiency directed by the V1–V5 regions during perinatal
transmission. Other factors such as the route and timing of
transmission may also be involved.
Introduction
Mother-to-child transmission of human immunodeficiency virus type 1
(HIV-1) remains the major route of infection for children in endemic
regions (Alcântara et al., 2012; Steain et al., 2006). This is especially
significant in sub-Saharan Africa where >90 % of infected children under
the age of 15 live and where the majority (95 %) of new paediatric infections
2
occurred, and where therapeutic intervention is still not widely available
(Ahmad, 2005; Luzuriaga, 2007; Zhang et al., 2010b). Moreover, HIV-1
subtype C is the most prevalent subtype and accounts for >60 % of
infections in this epidemic region. Given the absence of a prophylactic
vaccine or universal access to preventative treatment in these developing
countries, a clear understanding of the characteristics of preferentially
transmitted viruses is critical for the development of effective measures to
reduce rates of mother-to-child transmission.
Studies in multiple cohorts, across several HIV-1 subtypes, have shown that
only a limited number of viruses within the viral quasispecies are
transmitted during sexual transmission (Derdeyn et al., 2004; Keele et al.,
2008; Zhu et al., 1993) or perinatal transmission (Dickover et al., 2001;
Kishko et al., 2011; Scarlatti et al., 1993; Verhofstede et al., 2003; Wolinsky
et al., 1992). In fact, there are a number of host and viral factors that have
been suggested to affect the perinatal transmission of specific viral species,
including host neutralizing antibodies (Barin et al., 2006; Dickover et al.,
2006; Wei et al., 2003), the timing of transmission (Dickover et al., 2001)
and the R5 tropism of HIV-1 (Kishko et al., 2011; Verhofstede et al., 2003;
Wolinsky et al., 1992). However, there is no consensus on the mechanism
that accounts for the observed selective transmission bottleneck, implying a
complexity during perinatal transmission and underscoring the need to
explore further the genetic and biological determinants of this transmission
bottleneck.
We have centred our effectors on identifying cases of mother-to-child
transmission in a cohort in Zambia as part of ongoing efforts to understand
transmission and disease progression in HIV-1 subtype C infection. We
found previously that there was a restricted diversity in the infant viral
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quasispecies during perinatal transmission from mothers who were
chronically infected (Zhang et al., 2010b). Moreover, in the five chronically
infected mother–infant pairs (MIPs) analysed here, the infant viruses were
selected to have higher ex vivo fitness, as imparted by the V1–V5 regions of
the surface gp120 glycoprotein, than viruses of their corresponding mothers
(Kong et al., 2008). In contrast, we did not observe the same genotype and
phenotype selective transmission in our acutely infected pairs (Hoffmann et
al., 2008; Kong et al., 2008).
Glycoprotein gp120 directs HIV-1 entry into host cells by binding initially
to the CD4 receptors of target cells, resulting in dramatic conformational
changes in gp120 that expose the binding site for a secondary co-receptor.
Upon binding of gp120 to the co-receptor, further conformational changes in
gp120 lead to a gp41-mediated membrane fusion process that delivers the
viral core into the cytoplasm (Checkley et al., 2011). Given that gp120 has
an important impact on viral entry, we therefore explored further the
possibility that the V1–V5 regions of gp120 could affect gp41-mediated
fusion to confer higher replicative fitness to the infant viruses. Two
different fusion assays were employed to compare the fusogenicity elicited
by the V1–V5 regions derived from infant and maternal variants of the
seven Zambian MIPs in this study to determine whether the Env V1–V5
regions obtained from the infants and their mothers affected fusion
differentially to contribute to their differences in viral fitness and
subsequently their transmission.
Results
Characteristics of the seven MIPs
As summarized in Table 1, the maternal age at delivery was between 19 and
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31 years. The mode of delivery of all MIPs was vaginal except for MIP
2617, which was by caesarian section. The mothers of chronically infected
MIPs were known to be HIV-1 positive at the time of delivery and were
likely to have acquired HIV-1 infection heterosexually, whilst their infants
were HIV-1 negative at birth, suggesting that the infants were infected
either intrapartum or post-partum. For the acutely infected MIPs, mothers
and infants were found to have seroconverted at the same time point after
birth, suggesting that the infants were infected through breast-feeding. All
the mothers were asymptomatic without any clinical signs of
immunosuppression, and the infants were all breast-fed and drug naïve.
Infants of pairs 2617, 2669, 2873 and 1449 were considered rapid
progressors, as they died within the first year of life due to apparent HIV-
related complications.
See full table
Table 1. . Summary of clinical
information for the MIPs included in
this studyNA, Not applicable.
Fusogenic properties of Env containing V1–V5 regions from maternal
and infant HIV-1 variants of chronically and acutely infected MIPs
To determine whether the differences in replicative fitness conferred by the
V1–V5 regions between transmitted and non-transmitted variants of our
chronically infected MIPs were related to different viral entry efficiencies,
we compared the entry efficiency mediated by the V1–V5 regions derived
from the infant and maternal variants. A common surrogate assay of HIV-1
fusion and entry is the cell–cell fusion assay, where effector cells expressing
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HIV-1 Env (gp120/gp41) are co-cultured with target cells expressing the
CD4 receptors and CCR5/CXCR4 co-receptors (Deng et al., 1996). To
measure cell–cell fusion activity, we implemented two different assays. The
first was a fluorescent probe transfer system using COS-1 cells as effector
cells, which were transfected with the Env expression plasmids and loaded
with 7-amino-4-chloromethylcoumarin (CMAC; blue), and TZM-bl cells
loaded with the lipophilic octadecyl (C18) indocarbocyanine probe DiI (red)
and 5-chloromethylfluorescein diacetate (CMFDA; green) as the target. The
fused cells containing all three dyes were then quantified using fluorescence
microscopy (Fig. 1a). In parallel, a second assay was carried out using COS-
1 cells transfected with Env expression plasmids and TZM-bl cells
containing the luciferase reporter gene under the control of the HIV-1 long-
terminal-repeat promoter (indicator cells) (Fig. 1b). A luciferase signal was
emitted by the fused cells and used to measure cell–cell fusion mediated by
Env.
View larger version
Fig. 1. . Fusion assays. (a) Fluorescent microscopic images
of cell–cell fusion mediated by Env using a dye-transfer-based
assay. Effector (COS-1) cells expressing Env were labelled with
CMAC (blue). Target (TZM-bl) cells were co-labelled with DiI (red) and CMFDA
(green). Fluorescence images for each dye were acquired as shown. Fused cells are
depicted by arrowheads. (b) Schematic representation of the reporter gene-based
cell–cell fusion assay. TZM-bl cells were used as target cells and luciferase activity
was measured to indicate fusion.
We first analysed the chimaeric Env containing the viral V1–V5 regions of
the patients for their ability to induce cell–cell fusion using the fluorescent
probe transfer assay. The comparison of fusion efficiency between maternal
and infant variants of each MIP is shown in Fig. 2, left graphs). The results
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suggested that, in general, most of the Env proteins containing the V1–V5
regions of the transmitted variants exhibited comparable fusion efficiency
to the non-transmitted maternal variants derived from the five chronically
infected MIPs and two acutely infected MIPs. We also used the reporter
gene-based fusion assay to substantiate these results further (Fig. 2, right
panels). Similar results were observed when compared with the dye-transfer
assay. Moreover, none of the mean fusion rates of the chimaeric Env
containing infant V1–V5 regions was statistically different from those of the
mothers of the MIPs (Table S1, available in JGV Online).
View larger version
Fig. 2. . Comparison of the fusion efficiency between the infant
and maternal variants from MIP 1084 (a), MIP 2617 (b), MIP 2669
(c), MIP 2873 (d), MIP 1449 (e), MIP 2660 (f) and MIP 834 (g) using
a dye-transfer-based assay (left graphs) and a reporter gene-based
assay (right graphs). COS-1 cells were transfected with Env-expressing plasmids and
used as effector cells. TZM-bl cells were used as target cells. Maternal samples were
collected at the delivery, indicated as m0. Infants samples were collected at the time of
the first HIV PCR-positive result after birth, which for most infants was at 2 months
after birth (i2), for some was at 4 months (i4) and for some was at 6 months (i6). The
number after the dash indicates the clone number. Results are shown as means±SD
from three independent experiments.
However, we noted that all infant viral Env V1–V5 regions of MIP 2669 led
to higher fusion efficiency than most of the maternal V1–V5 regions except
for MIP 2669 m0-2, which had a fusion efficiency comparable to that of the
infant (Fig. 2c). To exclude the possibility that the expression level of the
chimaeric Env protein containing patients’ V1–V5 regions contributed to
differences between maternal and infant variants, we first tested the cell-
associated expression of Env glycoproteins containing the V1–V5 regions of
MIP 2669 and two other representative chronically infected MIPs (MIP
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1084 and MIP 2617). As shown in Fig. 3, we observed similar profiles for
the cell-associated Env glycoproteins. As synthesis of Env glycoproteins
appeared to be normal, we next examined the surface expression of Env
containing the V1–V5 regions derived from patients to determine whether
they were transported to and retained normally in the plasma membrane. In
this analysis, the cell-surface expression levels of all the Env glycoproteins
containing the infant and maternal V1–V5 regions of MIP 2669, MIP 1084
and MIP 2617 did not differ significantly (Fig. 4). These results indicated
that the V1–V5 regions of gp120 did not lead to viral envelope expression
differences to discriminate the transmitted and non-transmitted viruses.
Thus, in general, there seemed to be no consistent and significant
differences in fusogenicity induced by the V1–V5 regions between the
infant and maternal variants, although for MIP 2669 it appeared that the
infant V1–V5 regions induced a higher fusion efficiency than most of the
maternal Env glycoproteins.
View larger version
Fig. 3. . Expression profiles of Env glycoproteins containing the
V1–V5 regions derived from MIP 2669 (a), MIP 1084 (b) and MIP
2617 (c). COS-1 cells transiently transfected with simian virus 40
(SV40)-based Env expression vectors containing the V1–V5 regions
derived from patients were collected at 48 h post-transfection, lysed
and analysed by SDS-PAGE. Detection of actin was used as a
loading control.
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View larger version
Fig. 4. . Cell-surface levels of Env glycoprotein containing the V1–
V5 regions derived from three chronically infected MIPs. COS-1 cells
transfected with Env expression plasmids containing the V1–V5
regions derived from patients were fixed at 48 h post-transfection,
labelled with anti-gp120 HIV antibody and analysed by flow
cytometry. The surface levels of Env derived from MIP 2669 (a), MIP
1084 (b) and MIP 2617 (c) are shown as the relative mean
fluorescence index (MFI) compared with that of strain NL4-3 Env.
Results are shown as means±SD from three independent
experiments.
Env containing maternal V1–V5 regions shows delayed cell–cell
fusion kinetics when compared with that of their infants from MIP
2669
As MIP 2669 showed a trend where the infant V1–V5 regions induced a
higher fusion efficiency than most of the maternal V1–V5 regions, we
measured the kinetics of cell–cell fusion induced by the V1–V5 regions
using a reporter gene-based assay. As shown in Fig. 5(a), Env containing
maternal V1–V5 regions (m0-3 and m0-4), which showed a low fusion
efficiency (Fig. 2c) exhibited a lag time of about 2 h prior to the onset of
fusion compared with the infant Env glycoproteins, after which they
displayed a steady increase in luciferase activity, reaching a plateau at about
12 h, whilst m0-2 displayed a similar fusion profile to the infant Env
glycoproteins. We then compared the mean values of the fusion kinetics of
all Env containing infant and maternal V1–V5 regions (Fig. 5b). Env
containing infant V1–V5 regions showed a higher overall initial rate
between 4 and 6 h (14-fold versus eightfold h−1, respectively) than maternal
variants in inducing cell–cell fusion. Moreover, the infant and maternal
fusion kinetics were distinguishable from each other by reaching different
peak fusion levels. In addition, the time to half-maximal fusion of Env
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containing infant V1–V5 regions was shorter than that of the mothers (7.4
versus 8.3 h, respectively). In conclusion, for MIP 2669, the Env
glycoprotein containing the V1–V5 regions of infant variants exhibited a
trend of faster fusion kinetics when compared with Env containing the V1–
V5 regions of the maternal variants.
View larger version
Fig. 5. . Kinetics of cell–cell fusion mediated by the
V1–V5 regions of infant and mother derived from MIP
2669. COS-1 cells transfected with Env containing the V1–V5 regions from chronically
infected MIP 2669 were mixed with TZM-bl indicator cells and co-cultured for 2, 4, 6, 8,
10, 12 and 16 h before measuring the luciferase activity. (a) The relative luciferase
activities of each infant and maternal variant were calculated at each time point and
plotted as a single line. Results are shown as means±SD of at least three independent
experiments. (b) Relative luciferase activities of all maternal and infant variants.
Results are shown as means±SEM of infant and mother.
The higher fusogenicity induced by the V1–V5 regions of infant
variants of MIP 2669 compared with the maternal variants is
determined mainly by the V4–V5 regions
To investigate why Env containing maternal V1–V5 regions of MIP 2669
exhibited a low fusion efficiency compared with that of the infant variants,
we first compared the sequence of the V1–V5 regions of all the infant and
maternal variants of MIP 2669. Inspection of the variation between the
infant and maternal variants revealed that the most variable areas were the
V1–V2 loop, the V3 loop, the 5′ end of C3 and the variable loops V4 and V5
(Fig. 6). To determine which of these regions might contribute to the higher
fusion efficiency of the infant Env, the V1–V2 and V4–V5 regions of the
maternal variants were replaced with those of the infant variants (Fig. 7a).
As shown in Fig. 7(b), the low fusion efficiency of Env containing maternal
V1–V5 regions was moderately rescued when the V1–V2 regions were
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replaced by the infant V1–V2 regions. However, a fusion efficiency
equivalent to that of the infant variants was observed when the maternal
V4–V5 region was replaced by the V4–V5 region of the infant variants. In
conclusion, the V4–V5 regions may play an important role in affecting
fusion efficiency and distinguishing the differences between the maternal
and infant variants of MIP 2669.
View larger version
Fig. 6. . Alignment of deduced amino acid sequences of the Env
glycoprotein spanning the V1–V5 regions derived from chronically
infected MIP 2669. Amino acid identity (.), insertions/deletions (–)
and substitutions are indicated.
View larger version
Fig. 7. . Identification of V4–V5 regions responsible for the high
fusion efficiency of infant variants compared with the maternal
variants in MIP 2669. (a) Schematic representation of chimaeric Env
constructs of MIP 2669. (b) Comparison of the fusion efficiency of
wild-type mother and infant and chimaeric Env using a reporter gene-
based assay.
Discussion
Our overall results suggested that, in general, most of the chimaeric Env
containing the V1–V5 regions derived from the infant variants exhibited a
fusion efficiency comparable to that of the maternal variants in chronically
or acutely infected MIPs. It seems likely that the selective higher fitness in
chronically infected MIPs during perinatal transmission is not driven
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exclusively by selection of viruses with a significantly higher entry
efficiency mediated by the V1–V5 regions from the maternal viral
population. These results contrast with those reported by Marozsan et al.
(2005) studying the replication fitness of different HIV-1 subtypes, who
demonstrated that a subtype B isolate had a higher replicative fitness than a
subtype C isolate, and that its higher fitness correlated with a higher fusion
ability imparted by the V1–V5 region. These discrepancies may be due to
inter-subtype differences in the Env V1–V5 regions of subtype C viruses.
Moreover, in our study, the transmitted and non-transmitted viruses were
from the same viral quasispecies (Zhang et al., 2010b). Alternatively,
although the fusion ability induced by the Env V1–V5 regions between
transmitted and non-transmitted viruses was comparable, Env harbouring
V1–V5 regions of transmitted viruses may act more subtly to overcome the
non-transmitted viruses during perinatal transmission. Indeed, this has been
observed in our own and other previous studies, where the differences in
viral fitness could only be differentiated by direct competition (Martinez-
Picado et al., 2006; Zhang et al., 2010a).
However, we also noted that, in one of our chronically infected pairs, MIP
2669, where the infant was a rapid progressor, most of the Env
glycoproteins containing maternal V1–V5 regions exhibited a lower fusion
efficiency than Env containing the infant V1–V5 regions and displayed
delayed cell–cell fusion kinetics compared with the infant variants.
Sequence comparison of the maternal and infant variants of MIP 2669, and
results obtained from chimaeric Env variable region clones, demonstrated
that the V4–V5 regions of the Env glycoprotein may undergo selective
changes in a non-random fashion to produce the transmitted infant variants
harbouring higher fusion efficiencies. Our results with MIP 2669 support
our previous study demonstrating that high levels of non-synonymous
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variation occurred within the V1/V2 loops, V4 and V5 regions, and that
potential N-glycosylation site changes also generally occurred within the
V1, V2 and V4 regions (Zhang et al., 2006, 2010b). In addition, a previous
study also suggested that that the V4 region was involved in Env
conformation change and glycan packing (Wei et al., 2003).
A number of gp120 structures have provided a wealth of information on the
mechanism of gp120 interactions with CD4, co-receptor and gp41 (Chen et
al., 2005; Pancera et al., 2010; Wyatt et al., 1998). These studies also
suggested that, in addition to binding to receptors, gp120 plays an important
role in the viral membrane to subsequently affect viral fusion with target
cells. Several studies have demonstrated that mutations impacting on the
stability of CD4-binding sites and several residues in the V3 domain could
contribute to final viral fusogenicity (Gray et al., 2011; Rossi et al., 2008;
Sterjovski et al., 2007, 2011). We found that the V4–V5 regions affected the
fusion efficiencies of Env derived from the MIP 2669, even though V4–V5
has not been shown previously to participate in CD4 or co-receptor binding.
It is possible that the V4–V5 region of the infant Env variants may confer
subtle conformational changes in gp120 to induce more-efficient fusion.
Further studies will be needed to elucidate fully the specific determinants
within the V4–V5 region that enable it to induce a higher fusogenicity.
Although MIP 2669 showed a trend of selection of special V4–V5 regions to
lead to a final higher fusogenicity and faster fusion kinetics, we could not
exclude the possibility that this was sample dependent. Therefore, more
samples with this sequence specificity will be needed to confirm our
observations further. Nevertheless, our findings still provide some insight
into the features of gp120 that could be associated with its enhanced fusion
ability and how this may contribute to the bottleneck selection during
perinatal transmission.
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It has been reported that there is selection of single or minor variants to be
transmitted perinatally (Briant et al., 1995; Dickover et al., 2001). For MIP
2669, the transmission of a single maternal variant appeared to have
occurred partially due to the selection of variants that harboured the V1–V5
regions to induce higher Env fusion efficiency, whilst for the other
chronically infected MIPs, there could be other factors involved including
the timing and route of transmission (Briant et al., 1995; Dickover et al.,
2001; Kwiek et al., 2008) that may contribute to the seeding of minor
variants from the maternal quasispecies to initiate infection. Unfortunately,
the precise timing of transmission in our MIPs could not be determined, and
transmission could have occurred either late in utero or via early breast-
feeding, instead of being true intrapartum infection.
There are several lines of evidence to suggest that HIV-1 transmembrane
subunit gp41 modulates efficient intracellular transport and processing of
Env precursor gp160 and cell-surface expression either by glycan
components or by the cytoplasmic tail region (Bültmann et al., 2001; Dash
et al., 1994; Fenouillet & Jones, 1995). Moreover, mutations of gp120 could
also lead to impaired cleavage and export from the endoplasmic reticulum
of gp160 (Guo et al., 1990; Willey et al., 1991). Regarding our chimaeric
Env containing the variable V1–V5 regions derived from patients, which
shared the same signal peptide that targets Env to the endoplasmic
reticulum, as well as the same gp41 sequence, we wanted to investigate
whether the expression level of the chimaeric Env containing the V1–V5
regions of the patients contributed to differences between transmitted and
non-transmitted viruses by testing cell-associated and cell-surface
expression levels. No significant differences in the two modes were
observed either in MIP 2669 or in two other chronically infected MIPs.
These results, together with our previous pulse–chase analysis of the
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kinetics of synthesis and processing of these Env expression constructs
(Zhang et al., 2010a), suggest that the variability of gp120 V1–V5 regions
does not contribute to Env cellular biosynthesis, processing or stability after
gp120 reaches the plasma membrane to distinguish between maternal (non-
transmitted) and infant (transmitted) viruses.
One of the limitations in this study was that single-genome amplification
was not performed on these samples, as they were amplified previously
from the pooling of four to five diluted bulk PCRs, rather than from the bulk
PCR one time only. There is the possibility that PCR recombination in vitro
may have occurred to produce env genes that were not representative in
vivo. However, our previous phylogenetic analysis showed that the number
of unique sequences was large and was similar at each time point,
suggesting none of the clones was the result of in vitro PCR recombination
(Kong et al., 2008).
In conclusion, for the MIPs analysed, the fusogenicity elicited by the V1–V5
regions of Env may not be the exclusive factor that can impact on fitness
selection during perinatal transmission, although a trend towards higher
fusogenicity induced by the V1–V5 regions of transmitted infant variants
was observed in one chronically infected MIP analysed. Moreover, neither
Env biosynthesis nor cell-surface expression was predictive of virus
transmissibility in our cohort. Other virus properties, such as transmission
routes and timing, may also be involved.
Methods
Patient information and sample collection.
Seven MIPs (pairs 1084, 2617, 2669, 2873, 1449, 2660 and 834) were
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recruited into the study. This study was approved by the University of
Nebraska-Lincoln Institutional Review Board and the University of Zambia,
School of Medicine Research Ethics Committee. All study participants or
their parents provided written informed consent for the collection of
samples and subsequent analysis. Venous blood was collected from the
mother before delivery and from the infant within 24 h of delivery and at
subsequent time points. The mothers of five MIPs (pairs 1084, 2617, 2669,
1449 and 2873), which were defined as chronically transmitted MIPs, were
found to be infected at delivery, whilst their infants were HIV-1 negative at
birth. The infants of these MIPs were determined to be infected at either 2
months (pairs 2617, 2669, 1449 and 2873) or 4 months (1084) after birth.
Maternal samples collected at delivery and infant samples collected at the
first post-partum HIV-1 PCR-positive time point were defined as baseline
specimens, whilst for the other two MIPs (pairs 2660 and 834), which were
followed longitudinally from delivery, mothers and infants were found to
have seroconverted at the same follow-up time point after birth. MIPs 2660
and 834 were found to be infected at 18 and 4 months after birth,
respectively, when the baseline specimens were obtained. These two MIPs
were defined as acutely infected MIPs. The baseline HIV-1 serological
status of the mother was determined by two rapid assays, Capillus
(Cambridge Biotech) and Determine (Abbott Laboratories). Positive
serological results were confirmed by immunofluorescence assay, as
described previously (Mantina et al., 2001).
PCR, cloning and expression of Env derived from patients.
To obtain the pro-viral HIV-1 env gene, genomic DNA was extracted from
uncultured PBMCs for all subjects except mother 1084. For mother 1084,
the env gene was amplified from placental tissue as PBMCs were not
available. The env sequences of our samples were generated previously
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from pooling of several diluted PCRs rather than from one bulk PCR. We
eliminated potential recombinants, and our previous studies showed that the
number of unique sequences was large and was similar at each time point
analysed (Hoffmann et al., 2008; Zhang et al., 2006). This suggests that
pooling of several individual PCR products was adequate to prevent virus
template resampling in our study. Nested PCR was used to amplify a 1100
bp fragment spanning the V1–V5 region of env. The primers and PCR
parameters used were as described previously (Zhang et al., 2006).
Amplified fragments were cloned into a pGEM-T Easy vector (Promega)
and sequenced in both directions with dideoxy terminators (ABI BigDye
kit). A total of 20–40 clones were sequenced for each sample to obtain a
representative measurement for the diversity of the viral population
genotypes.
To obtain the Env expression constructs, the Env V1–V5 region was
amplified from the pGEM-T Easy vector using primers containing
restriction enzyme sites DraIII and AvrII: sense primer C-DraIII (5′-
TGACCCCACTCTGTGTCACTTTA-3′) and antisense primer C-AvrII (5′-
CTATTCCTAGGGGCTTAATTTCTACCACTT-3′). The PCR products were
subcloned into a shuttle vector, pSP72 NLA/S/Av (env gene of strain NL4.3
modified with AgeI/SbfI/AvrII for cloning purposes), using the restriction
enzyme sites DraIII and AvrII. Finally, the patient V1–V5 regions of env
were cloned into the Env expression vector pSRH NLA/S/Av, which was
generated by modifying the mammalian expression vector pSRH containing
an SV40 promoter and reading frames for NL4-3 Tat, Rev and Env (kindly
provided by Dr Eric Hunter, Emory University, GA, USA). All the patient-
derived chimaeric Env expression constructs were first screened for
biological function using a fusion assay (Derdeyn et al., 2004). Between
four and seven clones from each of the pools of sequenced Env clones from
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each sample were selected for the fusion analysis. The Env clones were
selected from each MIP based on the following criteria: (i) whether the Env
clones were functional; (ii) the length of the Env V1–V5 fragment; (iii) the
branch length of each Env in the phylogenetic tree; and (iv) the number of
putative N-linked glycosylation sites. To eliminate the possibility that the
clones selected for the analysis could be outliers, we then calculated the
divergence for each selected clone of the MIP as the genetic distance
between any sequence and the most recent common ancestor of the total
previously analysed archived virus sequences. This showed that divergence
from each selected Env was within the range of the characterized population
and that no outlier of divergence was used in our analysis (Kong et al.,
2008).
Cells and cell cultures.
TZM-bl cells and COS-1 cells were maintained in Dulbecco’s modified
Eagle’s medium (DMEM) with 10 % FBS, penicillin (50 U ml−1) and
streptomycin (50 µg ml−1).
Fluorescence microscopy assay for cell–cell fusion.
The assay was based on calculation of dye-transfer events between
fluorescently labelled target and effector cells, as described previously
(Cohen & Melikyan, 1998; Muñoz-Barroso et al., 1998). COS-1 cells
expressing Env (designated the ‘effector cells’) were labelled with the
cytoplasmic marker CMAC (Molecular Probes). TZM-bl cells (the ‘target
cells’) were co-labelled with the cytoplasmic marker CMFDA (Molecular
Probes) and DiI (Molecular Probes). Briefly, a confluent monolayer of COS-
1 cells on a poly-L-lysine (Sigma)-coated slide (1×105 cells) was washed
twice with PBS and incubated for 30 min at 37 °C with DMEM containing
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30 µM CMAC. The TZM-bl cells (3×105 cells) were co-labelled with 5 µM
CMFDA and 1 µM DiI in DMEM. To induce fusion, fluorescently labelled
effector cells and target cells were then co-cultured at 37 °C for 3 h. The
fusion events were assessed by fluorescence microscopy. For each sample,
fusion events from at least five random different fields were collected, and
the data were analysed by overlaying the images using Image-Pro Plus
software. The extent of fusion was calculated as the ratio of fused cells
(positive for all three dyes) to the sum of fused cells and the number of
effector–target cell pairs that did not fuse (Abrahamyan et al., 2003).
Luciferase reporter gene fusion assay.
COS-1 cells (1×105) were transfected with Env plasmid in 12-well plates
using polyethyleneimine (Sigma). Twenty-four hours later, the transfected
cells were co-cultured with TZM-bl cells (3×105) for another 24 h. The cells
were then rinsed with PBS, lysed with lysis buffer (Promega) and
centrifuged at 13 201 g for 3 min. The clarified lysate (5 µl) was mixed with
luciferin reagent (Promega) and the luciferase activity was measured using a
luminometer according to the manufacturer’s instructions (Promega).
Cell-surface expression of Env glycoprotein.
COS-1 cells were transfected with the Env expression vectors. At 48 h post-
transfection, the cells were harvested using PBS supplemented with 0.5 mM
EDTA, 0.5 mM EGTA and 180 mM glucose. The cells were fixed for 30 min
at 4 °C in 4 % paraformaldehyde (in PBS, pH 7.2). The fixed cells were then
incubated with primary antibody (anti-HIV Ig; National Institutes of Health)
and washed extensively, and binding of the primary antibody to the cells
was detected with Alexa Fluor 488-conjugated goat anti-human antibody
(Invitrogen). The mean fluorescence intensity (MFI) and percentage of
19
fluorophore-positive cells were detected using a FACSCalibur system (BD
Biosciences).
Western blot analysis of HIV-1 proteins.
For analysis of the expression of Env proteins, the transfected COS-1 cells
were lysed with NP-40 lysis buffer [0.5 % NP-40, 0.1 % Triton X-100, 0.1 %
sodium deoxycholate, 10 mM Tris/HCl (pH 8), 150 mM NaCl, 1 mM
EDTA] containing 1 % PMSF for 30 min on ice (Furuta et al., 2006). After
centrifugation at 10 000 g for 10 min at 4 °C, the supernatant was analysed
by SDS-PAGE (10 % acrylamide) and immunoblotted using sheep anti-HIV-
1 gp120 polyclonal antibody (National Institutes of Health). Primary
antibodies were detected with HRP-conjugated rabbit anti-sheep secondary
antibody (ZSGB-BIO), and the gp160 and gp120 bands were visualized by
chemiluminescence (Lassen et al., 2009).
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Table 1. . Summary of clinical information for the MIPs
included in this study
NA, Not applicable.
Subject
Age
(years)*
Birth
weight
(g)
Mode of
delivery
Breast-
feeding
Time
point
analysed
(month)†
No. of
clones
analysed
MIP
1084
 
Mother
28 NA NA NA M0 3
 
Infant,
male
NA 3400 Vaginal Yes 6 3
MIP
27
2617
 
Mother
20 NA NA NA M0 3
 
Infant,
female
NA 2560
Caesarean
section
Yes 2 3
MIP
2669
 
Mother
19 NA NA NA M0 3
 
Infant,
male
NA 3260 Vaginal Yes 2 3
28
MIP
2873
 
Mother
31 NA NA NA M0 4
 
Infant,
female
NA 3080 Vaginal Yes 2 3
MIP
1449
 
Mother
30 NA NA NA M0 2
 
Infant, NA 2540 Vaginal Yes 2 2
29
male
MIP
2660
 
Mother
21 NA NA NA 18 3
 
Infant,
male
NA 2760 Vaginal Yes 18 2
30
MIP
834
 
Mother
26 NA NA NA 4 3
 
Infant,
male
NA 3400 Vaginal Yes 4 2
*. Age of the mother in years at the time of delivery.
†. M0, Maternal samples at delivery were defined as baseline. The baseline samples of other
subjects were referred to the first HIV-1 PCR-positive time point, as indicated in months after infant
birth.
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Fig. 1. .
Fusion assays. (a) Fluorescent microscopic images of cell–cell fusion mediated by
Env using a dye-transfer-based assay. Effector (COS-1) cells expressing Env were
labelled with CMAC (blue). Target (TZM-bl) cells were co-labelled with DiI (red) and
CMFDA (green). Fluorescence images for each dye were acquired as shown. Fused
cells are depicted by arrowheads. (b) Schematic representation of the reporter
gene-based cell–cell fusion assay. TZM-bl cells were used as target cells and
luciferase activity was measured to indicate fusion.
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Fig. 2. .
Comparison of the fusion efficiency between the infant and maternal variants from
MIP 1084 (a), MIP 2617 (b), MIP 2669 (c), MIP 2873 (d), MIP 1449 (e), MIP 2660 (f)
and MIP 834 (g) using a dye-transfer-based assay (left graphs) and a reporter gene-
based assay (right graphs). COS-1 cells were transfected with Env-expressing
plasmids and used as effector cells. TZM-bl cells were used as target cells. Maternal
samples were collected at the delivery, indicated as m0. Infants samples were
collected at the time of the first HIV PCR-positive result after birth, which for most
infants was at 2 months after birth (i2), for some was at 4 months (i4) and for some
was at 6 months (i6). The number after the dash indicates the clone number. Results
33
are shown as means±SD from three independent experiments.
[Back]
34
[Back]
35
36
Fig. 3. .
Expression profiles of Env glycoproteins containing the V1–V5 regions derived from
MIP 2669 (a), MIP 1084 (b) and MIP 2617 (c). COS-1 cells transiently transfected
with simian virus 40 (SV40)-based Env expression vectors containing the V1–V5
regions derived from patients were collected at 48 h post-transfection, lysed and
analysed by SDS-PAGE. Detection of actin was used as a loading control.
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Fig. 4. .
Cell-surface levels of Env glycoprotein containing the V1–V5 regions derived from
three chronically infected MIPs. COS-1 cells transfected with Env expression
plasmids containing the V1–V5 regions derived from patients were fixed at 48 h
post-transfection, labelled with anti-gp120 HIV antibody and analysed by flow
cytometry. The surface levels of Env derived from MIP 2669 (a), MIP 1084 (b) and
MIP 2617 (c) are shown as the relative mean fluorescence index (MFI) compared
with that of strain NL4-3 Env. Results are shown as means±SD from three
independent experiments.
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Fig. 5. .
Kinetics of cell–cell fusion mediated by the V1–V5 regions of infant and mother
derived from MIP 2669. COS-1 cells transfected with Env containing the V1–V5
regions from chronically infected MIP 2669 were mixed with TZM-bl indicator cells
and co-cultured for 2, 4, 6, 8, 10, 12 and 16 h before measuring the luciferase
activity. (a) The relative luciferase activities of each infant and maternal variant were
calculated at each time point and plotted as a single line. Results are shown as
means±SD of at least three independent experiments. (b) Relative luciferase activities
of all maternal and infant variants. Results are shown as means±SEM of infant and
mother.
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Fig. 6. .
Alignment of deduced amino acid sequences of the Env glycoprotein spanning the
V1–V5 regions derived from chronically infected MIP 2669. Amino acid identity (.),
insertions/deletions (–) and substitutions are indicated.
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Fig. 7. .
Identification of V4–V5 regions responsible for the high fusion efficiency of infant
variants compared with the maternal variants in MIP 2669. (a) Schematic
representation of chimaeric Env constructs of MIP 2669. (b) Comparison of the
fusion efficiency of wild-type mother and infant and chimaeric Env using a reporter
gene-based assay.
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